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Edited by Stuart FergusonAbstract N-terminal acetylation was uncovered in paenibacil-
lin, a novel lantibiotic recently reported as a product of Paeniba-
cillus polymyxa OSY-DF. This N-terminal modiﬁcation is
unprecedented among bacteria-derived antimicrobial peptides
and further illustrates the broad range of modiﬁcations that
can occur in lantibiotics. Additionally, the primary structure of
paenibacillin has been ﬁnally determined unequivocally by the
extensive NMR analysis taken together with previous MS/MS
results. These analyses revealed the structure of paenibacillin
as one of the most post-translationally modiﬁed lantibiotics.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Lantibiotics are antimicrobial peptides produced by some
Gram-positive bacteria and typically contain (i) the dehy-
drated residues, a,b-didehydroalanine (Dha) and a,b-didehyd-
robutyric acid (Dhb), and (ii) the intramolecular thioether rings
of lanthionine (Lan) and b-methyllanthionine (MeLan)
(Fig. 1) [1,2]. Besides these common features, a diverse array
of other post-translational modiﬁcations have also been re-
ported [2].
Recently we isolated a novel lantibiotic, named paenibacil-
lin, and presented its characterization [3]. The peptide, pro-
duced by Paenibacillus polymyxa OSY-DF, is active against
many foodborne pathogenic and spoilage bacteria while pos-
sessing physical–chemical properties of signiﬁcance in practicalAbbreviations: 2D, two-dimensional; A, alanine moiety of lanthionine
and b-methyllanthionine; Abu, b-methylalanine moiety of b-methyl-
lanthionine; Dha, a,b-didehydroalanine; Dhb, a,b-didehydrobutyric
acid; DQF-COSY, double-quantum ﬁltered correlation spectroscopy;
HMBC, heteronuclear multiple bond correlation; HSQC, heteronu-
clear single-quantum coherence spectroscopy; Lan, lanthionine or A-S-
A; MeLan, b-methyllanthionine or Abu-S-A; MS/MS, tandem mass
spectroscopy; NMR, nuclear magnetic resonance; NOE, nuclear
Overhauser eﬀect; NOESY, NOE spectroscopy; ROESY, rotating-
frame NOESY; TOCSY, total correlation spectroscopy
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doi:10.1016/j.febslet.2008.07.008application. A tentative sequence was proposed based on tan-
dem mass spectroscopy (MS/MS) analysis: (X-Dha/Dhb)-(L/I)-
(L/I)-K-Dhb-Dhb-(L/I)-K-V-A-K-A-V-A-K-Abu-(L/I)-Abu-A-
(L/I)-A-Abu-G-A-A-Dha-N-A-(K/Q), where A and Abu are
alanine and b-methylalanine moieties engaged in the formation
of Lan (A-S-A) or MeLan (Abu-S-A). In an eﬀort by nuclear
magnetic resonance (NMR) methodology to resolve the ambi-
guities highlighted in parentheses as well as to determine the
ring formation, we discovered an N-terminal acetylation in
paenibacillin which is unprecedented among bacteria-derived
antimicrobial peptides. The ﬁnding further expands the broad
range of post-translational modiﬁcations that have been ob-
served in lantibiotics.
2. Materials and methods
2.1. Puriﬁcation of paenibacillin and detection of native lantibiotic in
fermentation broth
Paenibacillin was produced in P. polymyxa OSY-DF cultures and
puriﬁed as described previously [3]. Aliquots of the culture fermentate
were withdrawn aseptically at 0, 12 and 24 h of fermentation and ana-
lyzed by mass spectroscopy for the native form of the lantibiotic [3].
2.2. NMR experiments
The puriﬁed and lyophilized paenibacillin was dissolved in either
99.996% D2O or 90% H2O/10% D2O (referred to as H2O hereafter),
resulting in peptide concentrations of roughly 0.7 and 2.8 mM, respec-
tively. NMR experiments were carried out at 293.9 K on a Bruker
DMX-600 spectrometer equipped with a triple-resonance probe and
three-axis gradient coils. They include (i) 2D 1H-homonuclear experi-
ments DQF-COSY, TOCSY, NOESY, and ROESY, (ii) 2D 1H–13C
heteronuclear experiments HSQC, HMBC, HSQC-TOCSY, HSQC-
NOESY and HSQC-ROESY at natural 13C abundance, and (iii) 2D
1H–15N HSQC at natural 15N abundance (Supplementary Table 1).
Some experiments were repeated at 287.3 and/or 301.8 K to resolve
resonance overlapping. Water suppression was typically achieved by
pre-saturation for the sample in D2O and 3-9-19 WATERGATE [4]
for the sample in H2O. Data were processed with Bruker XWINNMR
3.5. Chemical shifts were referenced to an external standard DSS [5]
and deposited in the BioMagResBank (BMRB access code 15489).
3. Results
3.1. Paenibacillin in fermentation broth
Since degradation may occur during chemical isolation and
puriﬁcation process [6,7], the fermentation broth was sampled
during the 24 h of incubation followed by direct MALDI-MS
analysis. The result conﬁrms that the compound puriﬁed and
analyzed is the direct metabolite of P. polymyxa OSY-DF
(Fig. 2). The noteworthy stability of paenibacillin was also evi-
dent in NMR studies in which the 1D 1H spectrum of the same
sample was reproduced during several months of storage.European Biochemical Societies.
Fig. 1. Modiﬁed residues found in paenibacillin.
Fig. 2. Detection of native paenibacillin by MALDI-MS as described previously [3]. An identical mass to the HPLC-puriﬁed paenibacillin was
detected in the fermentate taken at 12 and 24 h of fermentation, but not at 0 h.
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For NMR sequencing, a well-established approach [6–12]
was followed, in which amino acid contents were examined fol-
lowed by sequential assignment. The 2D 1H–15N HSQC re-
vealed a total of 32 un-aliased cross-peaks with a small 15N
spectral width in the experiment set up (Fig. 3), including a
pair apparently attributed to the side-chain amide group of
either an Asn or a Gln residue. The existence of Lys residues
is conﬁrmed by aliased clustered peaks attributed to the e-ami-
no groups. Since the N-terminal amide proton is typicallyundetectable due to rapid exchange with water, the data sug-
gested a peptide of 31 amino acids in length. The content
was further explored from the 2D 1H–13C HSQC. For exam-
ple, the modiﬁed residues were readily identiﬁed by their un-
ique 1H/13C cross-peaks such as Dha Hb1,b2/Cb  5.6/
116 ppm, Dhb Hb/Cb  6.70/130 ppm, and Abu Hb/Cb  3.50/
50 ppm, while the Ile residues by the most upﬁeld CHd13 peaks
(Supplementary Fig. 1). On the other hand, the scalar correla-
tions of the resonances within a spin network were established
via 2D DQF-COSY, TOCSY, and 2D 1H–13C HSQC-TOCSY
Fig. 4. 2D NOESY recorded in H2O (sm = 200 ms) showing the
sequential assignment. The HN(i)–HN(i + 1) cross-peak is labeled by
‘‘i’’.
Fig. 5. Evidence in 2D NOESY (sm = 200 ms) for the determination of
thioether bridge pairing. (a) Intra-bridge NOEs, denoted by asterisks,
between Abu Ha and A Hb1/b2 in Abu-S-AMeLan structures. (b) Intra-
bridge NOEs, denoted by asterisks, between A11 Hb and A15 HN, and
between A25 HN and A29 Hb.
Fig. 3. 2D 1H–15N HSQC showing the amide peaks labeled by the
ﬁnal sequence number. The aliased peaks (15N  35 ppm) are assigned
to Lys e-amino groups.
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Ala, taken together with the characteristic chemical shifts led
to the identiﬁcation of 30 residues: 2 Dha, 2 Dhb, 3 Abu, 7
A, 2 Ala, 1 Asn, 1 Gly, 4 Ile, 1 Leu, 5 Lys, and 2 Val. The
observation of four dehydrated amino acids is in agreement
with the isotope-induced mass shift in MS/MS [3], although
a Dha residue (Dha2) was inconclusive as discussed previously.
Finally, the total assignment was completed by observation of
relayed scalar connectivity from the side-chain aliphatic pro-
tons to the backbone amide protons via analysis of 2D
DQF-COSY and TOCSY, recorded in H2O. During this pro-
cess, the above 1H–15N HSQC served as a reference spectrum
in assigning overlapped amide protons (e.g. V10 and A13).
3.3. Sequencing analysis and identiﬁcation of bridging pattern
The sequential assignment was largely accomplished by
HN(i)–HN(i + 1) NOE walk along the polypeptide chain
(Fig. 4) and further substantiated by (1) the side-chain (Ha,
Hb, etc.) – backbone (HN) sequential NOE assignments, (2)
the NOESY data collected at 287.3 and 301.8 K, and (3) the
2D 1H–13C HMBC analysis in the amide proton region (e.g.
A1-Dha2 in Fig. 6d) [10]. As for the bridging topology, the
two Lan and three MeLan structures expected from 3 Abu
and 7 A were deduced from intra-bridge NOE assignments, be-
tween Abu Ha and A Hb1,b2 in MeLan, and between HN of one
A moiety and Hb,b2 across the sulfur atom in Lan [11] (Fig. 5).
The result led to the following pairing pattern: A11-S-A15,
Abu17-S-A20, Abu19-S-A22, Abu23-S-A26, and A25-S-A29. In
summary, the data obtained at this stage conﬁrms the MS/
MS results and addresses the previously reported ambiguities
[3], except the putative N-terminal residue. Virtually all of
the expected resonances have been assigned (Table 1) with
chemical shifts generally close to random-coil values of respec-
tive natural or modiﬁed amino acids [5–7,10–12]. Considering
that the cyclic ring structural entities are intertwined andaccount for half of the residues in A11-K30 stretch, the
conformation of the C-terminal part is expected to be extre-
mely rigid.
Table 1
Chemical shift assignments of paenibacillin in aqueous solution at pH 4.5, 293.7 K
Residue 1HN/15N 1Ha/13Ca (ppm) 1Hb/13Cb (ppm) Others 1H/13C (15N) and C 0 (ppm)
CH3–CO 2.02/24.3 C
0 176.6
A1 8.36/129.10 4.28/52.8 1.40/18.9 C 0 177.1
Dha2 9.76/125.06 –/137.8 5.66, 5.55/116.3 C 0 169.3
I3 8.08/119.40 4.18/61.6 1.89/38.5 C 0 175.9; CHc12 1.18/27.5; CH
c2
3 0.90/17.6; CH
d1
3 0.85/12.8
I4 8.17/124.38 4.22/60.9 1.85/38.3 C 0 176.2; CHc12 1.16, 1.47/27.4; CH
c2
3 0.83/17.5; CH
d1
3 0.81/12.6
K5 8.47/125.45 4.41/56.6 1.90, 1.82/33.2 C 0 176.3; CHc2 1.50, 1.42/24.9; CH
d
2 1.68/29.0; CH
e
2 2.98/41.9
Dhb6 9.73/122.09 –/130.4 6.70/136.9 C 0 169.0; CHc13 1.81/15.4
Dhb7 9.11/115.94 –/130.3 6.77/137.9 C 0 168.9; CHc13 1.75/15.4
I8 7.76/118.17 4.18/61.6 1.90/38.4 C 0 175.9; CHc12 1.48, 1.19/27.4; CH
c2
3 0.90/17.6; CH
d1
3 0.85/12.8
K9 8.27/123.46 4.30/56.3 1.78/32.8 C 0 176.3; CHc2 1.45, 1.38/25.0; CH
d
2 1.63/28.9; CH
e
2 2.98/41.9
V10 7.98/120.78 4.05/63.0 2.09/32.5 CH
c1;c2
3 0.94/21.2
A11 8.24/121.01 4.54/56.2 3.18, 3.03/36.2 C 0 174.0
K12 8.39/121.18 4.18/56.8 1.88/31.5 C 0 176.2; CHc2 1.44, 1.34/25.0; CH
d
2 1.65/28.9; CH
e
2 2.99/41.9
A13 7.98/122.82 4.26/54.5 1.49/19.1 C 0 178.0
V14 7.97/115.44 4.06/63.0 2.22/31.9 C 0 175.9; CHc1;c23 0.95/21.2
A15 7.91/119.62 4.55/55.8 3.08, 3.08/37.0 C 0 174.2
K16 7.94/121.75 4.26/57.2 1.82/32.5 C 0 177.4; CHc2 1.46, 1.37/25.0; CH
d
2 1.68/29.0; CH
e
2 2.97/41.9
Abu17 8.68/116.96 4.94/61.4 3.59/50.3 C 0 175.1; CHc13 1.34/23.2
L18 7.99/127.30 4.63/55.6 1.83, 1.59/40.6 C 0 178.1; CHc 1.50/27.3; CHd1;d23 0.97/24.0; 0.91/25.0
Abu19 9.37/121.36 4.80/62.4 3.48/46.7 C 0 175.2; CHc13 1.41/22.8
A20 7.78/121.33 3.90/59.5 3.76, 2.82/39.7 C 0 175.1
I21 8.32/117.07 4.40/60.8 2.00/37.8 C 0 175.2; CHc12 1.33, 1.08/26.9; CH
c2
3 0.89/17.9; CH
d1
3 0.87/13.5
A22 8.03/122.24 4.57/54.6 3.56, 2.80/40.8 C 0 174.9
Abu23 8.55/113.12 4.86/61.0 3.48/49.6 C 0 175.4; CHc13 1.34/22.7
G24 8.66/113.18 4.16, 3.64/46.3 C 0 173.8
A25 8.85/126.25 4.53/56.2 3.11, 2.97/33.8
A26 8.24/119.74 4.09/57.3 3.62, 2.85/37.0 C 0 173.3
Dha27 9.11/123.00 –/136.7 5.96, 5.68/113.2 C 0 168.3
N28 8.84/117.18 4.69/53.4 2.95, 2.72/37.4 C 0 174.2; NHd21 7.60/112.13; NHd22 6.89/112.13; Cc 177.9
A29 8.29/118.22 4.53/55.1 3.17, 2. 95/36.4 C 0 174.5
K30 8.51/122.94 4.33/56.4 1.91, 1.77/32.8 CH
c
2 1.42/25.0; CH
d
2 1.66/29.1; CH
e
2 2.96/41.9
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In the 2D 1H–13C HSQC, the signals – whether resolved or
overlapped – have been appropriately assigned in the above
analysis, with one exception resonating at 1H/13C  2.02/
24.3 ppm (Fig. 6a). The latter does not fall into any character-
istic region that belongs to either a naturally occurring amino
acid or one of the dehydrated or thioether residues. This peak
was ﬁrstly determined to be a methyl group moiety (designated
Me hereafter) based on the peak integration in 1D 1H NMR
(Supplementary Fig. 2), in which I21 Hb with virtually identi-
cal chemical shift has been taken into account. Secondly, Me
shows an absence of scalar correlations to other protons in
the 2D DQF-COSY and TOCSY. This is even manifested in
the 1D 1H NMR, as no J-splitting is discernable for the sharp
peak at 2.02 ppm dominated by the contribution of Me over
I21, suggesting that Me behaves like an isolated spin system
reminiscent of a 2-oxopropionyl (Oxp) group in epilancin K7
[7]. Thirdly, like Oxp protons, Me protons were revealed to
have a through-bond (most likely two-bond) correlation to a
carbonyl 13C 0 spin (Fig. 6b). However, the latter value is typ-
ical of a regular peptide bond (13C 0  176 ppm) rather than of
a diketone, such as 200.4 ppm in Oxp [7]. Lastly, a sizable
NOE was observed between Me 1H and A1 HN (Fig. 6c),
indicative of spatial proximity. In fact, their sequential rela-
tionship was ﬁrmly established via the 2D 1H–13C HMBC re-
corded in H2O (Fig. 6d), in which the analogous
13C 0(i)–1HN(i + 1) correlation was assigned between the afore-mentioned 13C 0 resonance and A1 HN. Aided by the peptide
mass measurement, it is concluded that Me is just part of an
acetyl group CH3–CO–, which functions as the N-terminal
capping to the sequence. As a ﬁnal proof, a commercial N-
acetyl-L-alanine was subjected to the parallel NMR investiga-
tions. Virtually identical chemical shifts (1H/13C/13C 0  2.00/
24.5/176.0 ppm) were observed for the corresponding spins
in this analogue compound. In conclusion, the paenibacillin
primary structure is as follows: CH3CO-
1A-Dha-I-I-K-Dhb-
Dhb-I-K-V-A(1)-K-A-V-A(1)-K-Abu(2)-L-Abu(3)-A(2)-I-A(3)-
Abu(4)-G-A(5)-A(4)-Dha-N-A(5)-K30, in which the numbers in
parentheses indicate the pairings of thioether bridge. The the-
oretical mass of 2983.5091 Da is identical to the mass measure-
ment within experimental error. A schematic representation of
paenibacillin structure is shown in Fig. 7.4. Discussion
Hampered by unknown genetic background and unantici-
pated N-terminal blockage, paenibacillin produced by a wild
strain of P. polymyxa was ﬁnally conclusively sequenced by
extensive NMR analysis taken together with the previous
MS/MS results. The peptide is revealed to have one of the
highest residue modiﬁcations among the lantibiotics ever re-
ported, in terms of the number of modiﬁed residues and the ex-
tent of modiﬁcations [1,2] (Supplementary Fig. 3). Most
Fig. 6. The elucidation ofMe (CH3–) moiety and N-acetyl (CH3–CO–)
capping. (a) An unusual cross-peak at 1H/13C  2.02 ppm/24.3 ppm in
2D 1H–13C HSQC. The I21 CHb, circled, is the only resonance in the
vicinity of theMe 1H dimension within the experimental resolution. (b)
2D 1H–13C HMBC experiment showing the two-bond J correlation of
Me protons to a carbonyl resonance (176.6 ppm) in analogy to the
methyl protons of A1 and A13. (c) NOE assignment between Me 1H
and A1 HN in 2D NOESY (sm = 200 ms). (d) 2D
1H–13C HMBC
assignments showing the through-bond correlations between 13C 0 in
CH3–CO– and A1 H
N, between A1 13C 0 and A1 HN, and between A1
13C 0 and Dha2 HN.
Fig. 7. Schematic representation of paenibacill
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of our knowledge – is the ﬁrst such a report among antimicro-
bial peptides with prokaryotic origin. While this modiﬁcation
is pervasive in eukaryotes, it is extremely rare in prokaryotes
[13–15]. An intriguing question is when, where and how this
Na-acetylation occurs, as the most common ones occur endog-
enously and co-translationally, catalyzed by N-acetyltransfer-
ases [13,15]. It is well-established that processing of
lantibiotics generally involves both intracellular and extracellu-
lar events [1,2]. In the lantibiotic-producing cell, the immediate
translational product, LanA, is synthesized as an inactive pre-
cursor (pre-propeptide), consisting of a N-terminal leader pep-
tide and a C-terminal propeptide [1,16]. After the propeptide
moiety undergoes post-translational modiﬁcation, the pre-pro-
peptide is transported across cytoplasmic membrane to the
extracellular environment via LanT. This event is followed
by a protease-mediated cleavage (LanP or the equivalent),
leading to the release of the mature lantibiotic [1,2]. Thus con-
sidering the exogenous maturation nature of lantibiotic, it is
postulated that the N-terminal acetylation may have occurred
by a unique post-translational and extracellular manner. The
ﬁnding undoubtedly warrants further investigations on the
physiology and genetics of P. polymyxa OSY-DF, which
may help in gaining insight into the lantibiotic modiﬁcations
in general and Na-acetylation in particular.
N-terminal acetylation is believed to protect proteins from
degradation [17]. It is also required for speciﬁc binding, inter-
action, protein assembly, and proper protein function [18–20].
Previously, we have discussed the advantages of paenibacillin
over nisin in suitability for antimicrobial formulation [3]. It
may be reasonable to assume that Na-acetylation contributes
to the desirable physical–chemical properties of paenibacillin,
although the exact biological role remains to be determined.
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